Domino’s Pizza, Drug Stock Pullbacks, and The Chemical Brothers

Roll Me Over Romeo!

Traders for whom trading stock gaps is a key element of their active investing will have another opportunity to ply their trade as shares of Domino’s Pizza (NYSE: DPZ) plunged more than eight and a half percent in Thursday’s session.

The stock, which was trading at new, 52-week highs, as recently as Monday, is now at new, two-week lows and trading short-term oversold for the first time since a five-day sell-off in the first half of February.

The gap down and continued selling intraday has earned the stock a positive, short-term edge of more than 2%. And with a two-point ratings upgrade earned midway through Thursday’s session, shares of Domino’s Pizza are on track to open Friday morning with “consider buying” ratings of 8 out of 10.

Traders interested in learning more about how to trade stock gaps should check out the new Connors Research Trading Strategy Series: How to Trade High Probability Stock Gaps by Larry Connors and Cesar Alvarez. More information is available below.

*

Amgen, Lilly Trade Lower

A handful of blue chip, drug stocks have pulled back toward levels where traders, historically and statistically speaking, have been more inclined to buy than sell in the short-term. Among these stocks are Amgen (NASDAQ: AMGN), which closed lower for a third day in a row on Thursday to finish just inside technically oversold territory, and Eli Lilly (NYSE: LLY). Shares of LLY have also pulled back for three consecutive sessions, but managed to finish near the highs of the day after opening near two-week closing lows.

Ahead of Friday’s open, both AMGN and LLY have modest, positive edges of more than a third of a percent, and neutral, 6 out of 10, ratings.

Last oversold just a few weeks ago, shares of AMGN rallied for five days in a row in response to a pullback that took the stock lower for four out of five trading days at the beginning of March. Eli Lilly’s last retreat to technically oversold levels, around the same time as the Amgen pullback, led to seven consecutive higher closes as the stock advanced to its highest levels since the beginning of the year.

*

Dow and DuPont: Can These Chemical Brothers Bounce Back?

Industrial stocks in general were selling off ahead of the final trading day of the week. The Industrial Select Sector SPDRS ETF (NYSE: XLI), one proxy of the industrial stock sector, has closed lower for three days in a row, all in technically oversold territory.

Typical of the short-term weakness in industrials is the pullback in industrial chemical company, Dow Chemical (NYSE: DOW). Shares of DOW have just begun to sell-off in the wake of the stock climbing to its highest levels in months, the profit-taking sending DOW lower for three consecutive sessions, and into short-term oversold territory above the 200-day moving average.

Although the stock has a neutral, 6 out of 10, rating as of Thursday’s close, DOW also has a significant, short-term edge of more than three-quarters of a percent.

The last time shares of Dow Chemical were trading oversold near the beginning of the month, traders responded to the two-day sell-off by sending DOW higher for seven out of the following nine trading days for a gain of more than 9%.

Interestingly, rival chemical concern DuPont (NYSE: DD) has closed lower for five days in a row ahead of trading on Friday. Yet while the stock shares with Dow Chemical a neutral, 6 out of 10, rating, shares of DuPont have a far more modest short-term edge of under a third of a percent. Given this, it may be the case that DuPont will require additional volatility before buyers are lured off the sidelines with any enthusiasm.

“If you rely on data, not opinion, to make your trading decisions, and you want the ability to choose the best variations to trade your strategies, you’ll find a lot to interest you in this guide.”

Click here to learn more about How to Trade High Probability Stock Gaps by Larry Connors and Cesar Alvarez.

David Penn is Editor in Chief of TradingMarkets.com

Have You Switched to ConnorsRSI?

ConnorsRSI is the first Quantified Momentum Indicator -- the next-generation improvement to traditional RSI indicators. At Connors Research, we are using it as an overlay to many of our best strategies to make them even better -- now you can, too.

Enter your email address to get your FREE download of our Introduction to ConnorsRSI - 2nd Edition - Trading Strategy Guidebook with newly updated historical results.

Disclaimer: The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.